BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250324T140000
DTEND;TZID=America/New_York:20250324T150000
DTSTAMP:20260426T050036
CREATED:20250213T203254Z
LAST-MODIFIED:20250213T203254Z
UID:30942-1742824800-1742828400@www.masslifesciences.com
SUMMARY:Microcredentials Webinar: Connecting Learning and Work through a “60-year Curriculum”
DESCRIPTION:In this session\, participants will consider factors revealing a changing paradigm of higher education that involves employer-recognized competencies (knowledge\, skills\, and abilities); stacking and laddering credentials to create onramps to further education and upskilling; and creating pathways to careers while advancing learners’ social and economic mobility. The work of HLC’s Credential Lab will also be featured in helping institutions transition toward this “Both / And” future of degrees with skills that serve talent needs.
URL:https://www.masslifesciences.com/event/microcredentials-webinar-connecting-learning-and-work-through-a-60-year-curriculum/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250224T150000
DTEND;TZID=America/New_York:20250224T160000
DTSTAMP:20260426T050036
CREATED:20250213T203053Z
LAST-MODIFIED:20250213T203053Z
UID:30940-1740409200-1740412800@www.masslifesciences.com
SUMMARY:Understanding the Ecosystem Webinar: Learn and Work Ecosystem Library and beyond
DESCRIPTION:In this conversation with Holly Zanville of the Learn and Work Ecosystem Library LEWL\, participants will learn about recent national and global trends in credentialing; discuss how policy plays a role in portability and stackability\, and be introduced to key findings and best practices learned through the development of the LEWL. Zanville will share her years of expertise in the development and promotion of credentialing research and implementation with ample time for questions and conversation throughout the session.
URL:https://www.masslifesciences.com/event/understanding-the-ecosystem-webinar-learn-and-work-ecosystem-library-and-beyond/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250122T120000
DTEND;TZID=America/New_York:20250122T130000
DTSTAMP:20260426T050036
CREATED:20241219T204141Z
LAST-MODIFIED:20241219T204141Z
UID:30023-1737547200-1737550800@www.masslifesciences.com
SUMMARY:Tax Incentives for Medtech You Can't Afford to Miss
DESCRIPTION:MassMedic is proud to host an info session for the MLSC’s Tax Incentive program. Join us on Jan. 22\, 2025 at 12 p.m. to learn more about how the program provides incentives to companies engaged in life sciences research and development\, commercialization and manufacturing in Massachusetts looking to expand their efforts by creating new\, long-term jobs in the state. \nIf your life sciences company is expecting to hire at least 10 net new jobs (or in some cases 5) in 2025\, the Tax Incentive program can offer incentives starting at $16\,000 per job\, with priority given to companies focused on manufacturing\, women’s health\, cell and gene therapy\, and improving health equity\, access\, and affordability.
URL:https://www.masslifesciences.com/event/tax-incentives-for-medtech-you-cant-afford-to-miss/
LOCATION:Virtual
ORGANIZER;CN="MassMEDIC":MAILTO:info@massmedic.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20250113T103000
DTEND;TZID=America/New_York:20250113T113000
DTSTAMP:20260426T050036
CREATED:20241219T204410Z
LAST-MODIFIED:20241219T204410Z
UID:30028-1736764200-1736767800@www.masslifesciences.com
SUMMARY:Tax Incentive Info Session
DESCRIPTION:For interested companies\, the MLSC offers info sessions on eligibility requirements\, various tax incentives available\, compliance and reporting requirements\, application process overview and timeline for awards. \nIf your life sciences company is expecting to hire at least 10 net new jobs (or in some cases 5) in 2025\, the Tax Incentive program can offer incentives starting at $16\,000 per job\, with priority given to companies focused on manufacturing\, women’s health\, cell and gene therapy\, and improving health equity\, access\, and affordability.
URL:https://www.masslifesciences.com/event/tax-incentive-info-session/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250108
DTEND;VALUE=DATE:20250220
DTSTAMP:20260426T050036
CREATED:20241112T191711Z
LAST-MODIFIED:20241112T191711Z
UID:29170-1736294400-1740009599@www.masslifesciences.com
SUMMARY:Biotechnology Project Management Course
DESCRIPTION:Biotechnology Project Management examines critical aspects of project management\, including an overview of the drug development process and regulatory agencies. Participants learn to use tools and strategies for working in a team environment to analyze risk\, allocate resources\, track projects\, resolve conflicts\, make decisions\, and manage teams. Experiential learning labs\, class participation\, and real-world examples are used to maximize educational impact. \nDeadline to Register is December 19\, 2024
URL:https://www.masslifesciences.com/event/biotechnology-project-management-course/
LOCATION:Virtual
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241202
DTEND;VALUE=DATE:20241213
DTSTAMP:20260426T050036
CREATED:20241112T190723Z
LAST-MODIFIED:20241112T190723Z
UID:29168-1733097600-1734047999@www.masslifesciences.com
SUMMARY:Intro to Biotech\, Business & Science – December 2024
DESCRIPTION:The Intro to Biotech course is divided into two parts: Intro to Business and Intro to Science. We provide a significant discount when individuals take the course as a package. While you can choose to attend one or the other\, we highly recommend taking the course as a package to learn a more in-depth understanding of the biotech world. \nIntro to Science explore considerations that drive company strategies. Students will be provided with foundational information about the biopharma industry and regulation via instruction\, storytelling\, and small group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. The course touches on topics such as market share\, phases of development\, patient population\, safety profile\, and more.
URL:https://www.masslifesciences.com/event/intro-to-biotech-business-science-december-2024/
LOCATION:Virtual
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241202
DTEND;VALUE=DATE:20241206
DTSTAMP:20260426T050036
CREATED:20241112T185705Z
LAST-MODIFIED:20241112T185705Z
UID:29166-1733097600-1733443199@www.masslifesciences.com
SUMMARY:Transitioning to Leader – December 2024
DESCRIPTION:Transitioning to Leader provides participants with a clear understanding of the leader-manager they aim to be and the essential skills and strategies to get them there. Approaches to effective communication and how to foster collaboration among teams (both remotely and in person) are discussed. Participants will also discuss the leader’s role in fostering employee engagement.
URL:https://www.masslifesciences.com/event/transitioning-to-leader-december-2024/
LOCATION:Virtual
ORGANIZER;CN="MassBioEd":MAILTO:communications@massbioed.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241113T110000
DTEND;TZID=America/New_York:20241113T120000
DTSTAMP:20260426T050036
CREATED:20240919T211951Z
LAST-MODIFIED:20240919T211951Z
UID:27750-1731495600-1731499200@www.masslifesciences.com
SUMMARY:Virtual Info Session for Open Programs
DESCRIPTION:Attend a virtual info session to learn more about the following MLSC programs: \n\nWomen’s Health Innovation Grants\nWomen’s Health Collaboration program\nFirst Look Awards\nResearch Infrastructure\nBits to Bytes\nNovel Therapeutics Delivery\nHealth Equity Accelerator
URL:https://www.masslifesciences.com/event/virtual-info-session-for-open-programs-2/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241018T110000
DTEND;TZID=America/New_York:20241018T120000
DTSTAMP:20260426T050036
CREATED:20240919T211619Z
LAST-MODIFIED:20240919T211619Z
UID:27748-1729249200-1729252800@www.masslifesciences.com
SUMMARY:Virtual Info Session for Open Programs
DESCRIPTION:Attend a virtual info session to learn more about the following MLSC programs: \n\nWomen’s Health Innovation Grants\nWomen’s Health Collaboration program\nFirst Look Awards\nResearch Infrastructure\nBits to Bytes\nNovel Therapeutics Delivery\nHealth Equity Accelerator
URL:https://www.masslifesciences.com/event/virtual-info-session-for-open-programs/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20241001T103000
DTEND;TZID=America/New_York:20241001T113000
DTSTAMP:20260426T050036
CREATED:20240919T211451Z
LAST-MODIFIED:20240919T211833Z
UID:27745-1727778600-1727782200@www.masslifesciences.com
SUMMARY:Virtual Info Session for Open Programs
DESCRIPTION:Attend a virtual info session to learn more about the following MLSC programs: \n\nWomen’s Health Innovation Grants\nWomen’s Health Collaboration program\nFirst Look Awards\nResearch Infrastructure\nBits to Bytes\nNovel Therapeutics Delivery\nHealth Equity Accelerator
URL:https://www.masslifesciences.com/event/info-session-for-open-programs/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240731
DTEND;VALUE=DATE:20240801
DTSTAMP:20260426T050036
CREATED:20240710T102500Z
LAST-MODIFIED:20240710T102521Z
UID:24807-1722384000-1722470399@www.masslifesciences.com
SUMMARY:BIC Stage 2 Accelerator Application Deadline
DESCRIPTION:The MLSC is proud to sponsor the BIC Stage 2 Accelerator\, a 35-week hands-on and results-oriented program designed to serve early-stage tech startups that are building a physical product and moving toward the manufacturing phase. \n\n\nWith the BIC Stage 2 Accelerator\, they added structures to crystallize and expand our current offerings so that we can provide the full range of BIC resources to more entrepreneurs. The program will continue to leverage our existing strengths and assets and will be an opportunity to increase access\, expand our partnerships\, and activate more of the connections that we have built over the last four years.  This program is provided without cost to the selected startups and the BIC does not take any equity in the firms in exchange for the services provided.  \nThe deadline to apply for the 2024/2025 cohort is July 31\, 2024.
URL:https://www.masslifesciences.com/event/bic-stage-2-accelerator-application-deadline/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240628T110000
DTEND;TZID=America/New_York:20240628T120000
DTSTAMP:20260426T050036
CREATED:20240611T171658Z
LAST-MODIFIED:20240611T171658Z
UID:23940-1719572400-1719576000@www.masslifesciences.com
SUMMARY:Behind the Breakthroughs | Closing the Gap: Equity in Clinical Trials\, Research and Patient Care
DESCRIPTION:At Dana-Farber Cancer Institute\, we believe that skin color\, income\, and zip code should never determine health outcomes. Join Narjust Florez\, MD\, Associate Director of Dana-Farber’s Cancer Care Equity Program\, as she leads a discussion about the Institute’s efforts to translate research into clinical interventions that will reduce disparities in cancer outcomes. Leading clinicians and investigators in the fields of pediatric\, breast\, gastrointestinal\, and thoracic oncology will discuss how they are working to ensure that all patients can benefit from lifesaving advancements at Dana-Farber and beyond. Panelists include Kira Bona\, MD\, MPH\, Rachel Freedman\, MD\, MPH\, and Nadine McCleary\, MD\, MPH.
URL:https://www.masslifesciences.com/event/behind-the-breakthroughs-closing-the-gap-equity-in-clinical-trials-research-and-patient-care/
LOCATION:Virtual
ORGANIZER;CN="Dana-Farber Cancer Institute":MAILTO:DFCIandJimmyFundEvents@DFCI.HARVARD.EDU
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240530T110000
DTEND;TZID=America/New_York:20240530T120000
DTSTAMP:20260426T050036
CREATED:20240314T155844Z
LAST-MODIFIED:20240314T155844Z
UID:21632-1717066800-1717070400@www.masslifesciences.com
SUMMARY:MassNextGen Info Session
DESCRIPTION:Entrepreneur Hour: Please join us to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives. \nThe MassNextGen Initiative is a public-private partnership between the MLSC and our corporate sponsors\, Takeda\, Johnson & Johnson Innovation\, Mintz\, Berkshire Innovation Center\, InnoVenture Labs\, Massachusetts Biomedical Initiatives\, M2D2\, and Mansfield Bio-Incubator. \nThe application period is March 18 – June 14\, 2024.
URL:https://www.masslifesciences.com/event/massnextgen-info-session-6/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240424T100000
DTEND;TZID=America/New_York:20240424T110000
DTSTAMP:20260426T050036
CREATED:20240314T155323Z
LAST-MODIFIED:20240314T155323Z
UID:21628-1713952800-1713956400@www.masslifesciences.com
SUMMARY:MassNextGen Info Session
DESCRIPTION:Entrepreneur Hour: Please join us to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives. \nThe MassNextGen Initiative is a public-private partnership between the MLSC and our corporate sponsors\, Takeda\, Johnson & Johnson Innovation\, Mintz\, Berkshire Innovation Center\, InnoVenture Labs\, Massachusetts Biomedical Initiatives\, M2D2\, and Mansfield Bio-Incubator. \nThe application period is March 18 – June 14\, 2024.
URL:https://www.masslifesciences.com/event/massnextgen-info-session-5/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240410
DTEND;VALUE=DATE:20240412
DTSTAMP:20260426T050036
CREATED:20231108T203228Z
LAST-MODIFIED:20231114T155946Z
UID:20291-1712707200-1712879999@www.masslifesciences.com
SUMMARY:Drug Development Boot Camp®
DESCRIPTION:The Drug Development Boot Camp® provides intensive virtual training in new medicine development training\, to those who are already experts in the industry. This training is in its fourteenth year\, and has a reputation for being transformative. There is a reason that people say\, this is the training to take. \nDuring COVID the Drug Development Boot Camp® was moved to a virtual in real time format\, rather than skipping the training during lock-down. Many of you will remember that the training was run at the Harvard Club in Boston. We hope to return to face to face format eventually\, but we are remaining virtual to maximize the access. \nHundreds of people from the Boston/Mass region have taken this training. Isn’t it time that you looked into it? Register at www.drugstomarket.com/drugbootcamp \n$50 off for ‘MassLifeSci50’ code mention.
URL:https://www.masslifesciences.com/event/drug-development-boot-camp/
LOCATION:Virtual
ORGANIZER;CN="Speid & Associates%2C Inc.":MAILTO:LSPEID@SNDTM.COM
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240320T140000
DTEND;TZID=America/New_York:20240320T150000
DTSTAMP:20260426T050036
CREATED:20240314T155039Z
LAST-MODIFIED:20240314T155039Z
UID:21624-1710943200-1710946800@www.masslifesciences.com
SUMMARY:MassNextGen Info Session
DESCRIPTION:Entrepreneur Hour: Please join us to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives. \nThe MassNextGen Initiative is a public-private partnership between the MLSC and our corporate sponsors\, Takeda\, Johnson & Johnson Innovation\, Mintz\, Berkshire Innovation Center\, InnoVenture Labs\, Massachusetts Biomedical Initiatives\, M2D2\, and Mansfield Bio-Incubator. \nThe application period is March 18 – June 14\, 2024.
URL:https://www.masslifesciences.com/event/massnextgen-info-session-4/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231108T130000
DTEND;TZID=America/New_York:20231108T140000
DTSTAMP:20260426T050036
CREATED:20231025T172714Z
LAST-MODIFIED:20231025T172714Z
UID:20201-1699448400-1699452000@www.masslifesciences.com
SUMMARY:AI + Life Sciences: A Collaboration to Meet the Moment
DESCRIPTION:Driven by advances in AI and our ability to generate high-resolution data\, the life sciences industry is on the cusp of a second golden age. In this webinar\, Sam Scarpino\, director of AI + Life Sciences will discuss exciting advances at the intersection of AI and Life Sciences\, including how we are: \nFocusing on wet-lab-in-the-loop AI\, building platforms for drug discovery\, multiomic approach to understanding the systems biology of disease\, and global health security. \nReducing time-to-market and increasing confidence for therapeutics\, biologicals\, diagnostics and more. \nTalent acquisition\, Up-skilling Employees\, Sponsored Research\, Product Evaluation and Strategy and more \nSpecial conversation with Adam Bly\, CEO of System\, Inc. exploring challenges and opportunities in AI and Life Sciences \nSpeakers: \nSam Scarpino\, Director of AI + Life Sciences at Institute for Experiential AI\nAdam Bly\, CEO of System
URL:https://www.masslifesciences.com/event/ai-life-sciences-a-collaboration-to-meet-the-moment/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230623T110000
DTEND;TZID=America/New_York:20230623T120000
DTSTAMP:20260426T050036
CREATED:20230519T205006Z
LAST-MODIFIED:20230519T205006Z
UID:19157-1687518000-1687521600@www.masslifesciences.com
SUMMARY:MassNextGen Virtual Info Session
DESCRIPTION:Entrepreneur Hour: Please join us virtually to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives. \nThe new iteration of MassNextGen will increase funding to $100\,000 per awardee\, aim to double the cohort size to 10 entrepreneurs\, and expand entrepreneurs’ access and network to raise further funding by providing year-round networking sessions with the venture capital community. The MLSC and its sponsors will also hold a “pitch” event for awardees to highlight their company to sponsors\, awardees\, and representatives of venture capital firms.  \nThe MLSC and its sponsors are launching the next five years of MassNextGen to support all entrepreneurs that identify as: Female; Black\, African American\, or Afro Caribbean; Hispanic\, Hispanic American\, or Latinx/Latin; Indigenous\, Native American\, or First Nation; Asian American\, Pacific Islander\, or Native Hawaiian; Transgender\, Queer/Non Binary\, Nonconforming/Agender; Living with apparent or non-apparent disability\, or Neurodiverse; and Veteran and others.  \nA special thank you to our Anchor Platinum Sponsor\, Takeda\, and our Change Sponsors Berkshire Innovation Center\, Bristol Myers Squibb\, Johnson & Johnson Innovation\, M2D2\, Mansfield Bio-Incubator\, Massachusetts Biomedical Initiatives (MBI)\, Mintz\, and North Shore InnoVentures.
URL:https://www.masslifesciences.com/event/massnextgen-virtual-info-session-2/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230609T100000
DTEND;TZID=America/New_York:20230609T110000
DTSTAMP:20260426T050036
CREATED:20230515T143732Z
LAST-MODIFIED:20230515T143732Z
UID:19076-1686304800-1686308400@www.masslifesciences.com
SUMMARY:MassNextGen Virtual Info Session
DESCRIPTION:Entrepreneur Hour: Please join us virtually to learn how the MLSC supports diverse entrepreneurs and early-stage life science companies through MassNextGen and other initiatives. \nThe new iteration of MassNextGen will increase funding to $100\,000 per awardee\, aim to double the cohort size to 10 entrepreneurs\, and expand entrepreneurs’ access and network to raise further funding by providing year-round networking sessions with the venture capital community. The MLSC and its sponsors will also hold a “pitch” event for awardees to highlight their company to sponsors\, awardees\, and representatives of venture capital firms.  \nThe MLSC and its sponsors are launching the next five years of MassNextGen to support all entrepreneurs that identify as: Female; Black\, African American\, or Afro Caribbean; Hispanic\, Hispanic American\, or Latinx/Latin; Indigenous\, Native American\, or First Nation; Asian American\, Pacific Islander\, or Native Hawaiian; Transgender\, Queer/Non Binary\, Nonconforming/Agender; Living with apparent or non-apparent disability\, or Neurodiverse; and Veteran and others.  \nA special thank you to our Anchor Platinum Sponsor\, Takeda\, and our Change Sponsors Berkshire Innovation Center\, Bristol Myers Squibb\, Johnson & Johnson Innovation\, M2D2\, Mansfield Bio-Incubator\, Massachusetts Biomedical Initiatives (MBI)\, Mintz\, and North Shore InnoVentures.
URL:https://www.masslifesciences.com/event/massnextgen-virtual-info-session/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221102T090000
DTEND;TZID=America/New_York:20221102T100000
DTSTAMP:20260426T050036
CREATED:20221011T174916Z
LAST-MODIFIED:20221011T174916Z
UID:17728-1667379600-1667383200@www.masslifesciences.com
SUMMARY:Information Session: Master of Medical Sciences in Medical Education
DESCRIPTION:Please join us for a live information session on November 2 at 9:00 AM ET followed by a live question and answer session.
URL:https://www.masslifesciences.com/event/information-session-master-of-medical-sciences-in-medical-education/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221013T080000
DTEND;TZID=America/New_York:20221013T170000
DTSTAMP:20260426T050036
CREATED:20220902T113827Z
LAST-MODIFIED:20220902T113827Z
UID:17222-1665648000-1665680400@www.masslifesciences.com
SUMMARY:Capital Programs and Women's Health Programs - Virtual Info Session
DESCRIPTION:To learn more about the funding opportunities for our capital and women’s health programs listed below\, register for one of three virtual informational sessions MLSC staff will be hosting. \nSeptember 16\, 2022 at 11:30 a.m. – Register now\nSeptember 26\, 2022 at 2 p.m. – Register now\nOctober 13\, 2022 at 10:30 a.m. – Register now \nPrograms discussed: \nBits to Bytes: grants for scientific projects that generate and analyze large datasets to answer pressing life science questions\, and to attract and train data scientists in the Commonwealth. \nNovel Therapeutics Delivery: capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing\, to targeted delivery\, to biomaterials and more. \nResearch Infrastructure: grants for capital projects that catalyze the life sciences ecosystem in by accelerating life sciences research and development in the Commonwealth. \nFirst Look Awards: Supporting translational research at Massachusetts research institutions that furthers our understanding of sex and gender differences especially for diseases or conditions that affect women exclusively\, predominately\, or differentially. \nWomen’s Health Innovation Grants: Fostering the development of new technologies to deliver innovative therapies.
URL:https://www.masslifesciences.com/event/capital-programs-and-womens-health-programs-virtual-info-session/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220926T140000
DTEND;TZID=America/New_York:20220926T150000
DTSTAMP:20260426T050036
CREATED:20220902T113840Z
LAST-MODIFIED:20220902T113840Z
UID:17219-1664200800-1664204400@www.masslifesciences.com
SUMMARY:Capital Programs and Women's Health Programs - Virtual Info Session
DESCRIPTION:To learn more about the funding opportunities for our capital and women’s health programs listed below\, register for one of three virtual informational sessions MLSC staff will be hosting. \nPrograms discussed: \nBits to Bytes: grants for scientific projects that generate and analyze large datasets to answer pressing life science questions\, and to attract and train data scientists in the Commonwealth. \nNovel Therapeutics Delivery: capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing\, to targeted delivery\, to biomaterials and more. \nResearch Infrastructure: grants for capital projects that catalyze the life sciences ecosystem in by accelerating life sciences research and development in the Commonwealth. \nFirst Look Awards: Supporting translational research at Massachusetts research institutions that furthers our understanding of sex and gender differences especially for diseases or conditions that affect women exclusively\, predominately\, or differentially. \nWomen’s Health Innovation Grants: Fostering the development of new technologies to deliver innovative therapies.
URL:https://www.masslifesciences.com/event/capital-programs-and-womens-health-programs-virtual-info-session-3/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220916T113000
DTEND;TZID=America/New_York:20220916T123000
DTSTAMP:20260426T050036
CREATED:20220902T113831Z
LAST-MODIFIED:20220902T113831Z
UID:17217-1663327800-1663331400@www.masslifesciences.com
SUMMARY:Capital Programs and Women's Health Programs - Virtual Info Session
DESCRIPTION:To learn more about the funding opportunities for our capital and women’s health programs listed below\, register for one of three virtual informational sessions MLSC staff will be hosting. \nSeptember 16\, 2022 at 11:30 a.m. – Register now\nSeptember 26\, 2022 at 2 p.m. – Register now\nOctober 13\, 2022 at 10:30 a.m. – Register now \nPrograms discussed: \nBits to Bytes: grants for scientific projects that generate and analyze large datasets to answer pressing life science questions\, and to attract and train data scientists in the Commonwealth. \nNovel Therapeutics Delivery: capitalize and incentivize translational projects to address complex challenges in “therapeutic” delivery—from biomanufacturing\, to targeted delivery\, to biomaterials and more. \nResearch Infrastructure: grants for capital projects that catalyze the life sciences ecosystem in by accelerating life sciences research and development in the Commonwealth. \nFirst Look Awards: Supporting translational research at Massachusetts research institutions that furthers our understanding of sex and gender differences especially for diseases or conditions that affect women exclusively\, predominately\, or differentially. \nWomen’s Health Innovation Grants: Fostering the development of new technologies to deliver innovative therapies.
URL:https://www.masslifesciences.com/event/capital-programs-and-womens-health-programs-virtual-info-session-2/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220912T103000
DTEND;TZID=America/New_York:20220912T113000
DTSTAMP:20260426T050036
CREATED:20220831T135231Z
LAST-MODIFIED:20220831T135231Z
UID:17213-1662978600-1662982200@www.masslifesciences.com
SUMMARY:Angel Investor Tax Credit Program - Virtual Info Session
DESCRIPTION:To learn more about our Angel Investor Tax Credit program\, register for our virtual info session that is being held on Sept. 12 at 10:30 a.m. Both early-stage life science company and investor applicants should attend this virtual session to learn more about this program and talk directly with MLSC staff. \nDeadline to apply is Jan. 5\, 2023.
URL:https://www.masslifesciences.com/event/angel-investor-tax-credit-program-virtual-info-session/
LOCATION:Virtual
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220831T160000
DTEND;TZID=America/New_York:20220831T190000
DTSTAMP:20260426T050036
CREATED:20220816T174559Z
LAST-MODIFIED:20220816T174559Z
UID:17043-1661961600-1661972400@www.masslifesciences.com
SUMMARY:Virtual BioXchange
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s networking platform. Connect with life science colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event will be hosted on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to navigate between different group discussions within an interactive chatroom environment. The platform provides the closest experience to a live networking experience. \nParticipants are welcome to join the event at any point of time. The event is subject to run later than the posted end time as the room will stay open as long as people are actively engaged within the chat room. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-11/
LOCATION:Virtual
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220825T100000
DTEND;TZID=America/New_York:20220825T120000
DTSTAMP:20260426T050036
CREATED:20220822T210221Z
LAST-MODIFIED:20220822T210221Z
UID:17059-1661421600-1661428800@www.masslifesciences.com
SUMMARY:Engineering strategies for improving adoptive T cell therapy against cancer
DESCRIPTION:The adoptive cell transfer (ACT) of tumor-specific T cells has emerged as a potent treatment against some advanced cancers. For example\, ACT of ex vivo expanded tumor-infiltrating lymphocytes (TILs) has achieved durable and complete responses in about 20% of melanoma patients receiving a single transfusion. In addition\, TCR-redirected T cells targeting the cancer testis antigen NY-ESO-1157-165 have shown important clinical promise against melanoma\, myeloma\, and synovial sarcoma. Furthermore\, ACT with peripheral blood T cells gene-modified to express chimeric antigen receptor (CAR) T cells targeting the B-cell lineage antigen CD19 has led to complete remission for up to 90% of some advanced\, treatment-refractory hematological cancer patients. \nHowever\, unprecedented responses to CAR therapy have not been achieved against epithelial-derived solid tumors\, the most common category of cancers. Indeed\, solid tumors present a variety of barriers to CAR therapy\, including that there is a lack of tumor antigens not also found on healthy tissues\, thus running the risk of on-target but off-tumor toxicity. Hence\, both TCR- and CAR T cells face various immunosuppressive barriers in the solid tumor microenvironment (TME)\, which can be detrimental to their persistence and function. \nCreative Biolabs has invited Dr. Melita Irving to join us in this webinar section and discuss the latest findings of her research team on an innovative CAR design\, hoping to provide insights into the engineering strategies for improving the efficacy and safety of CAR and TCR cell therapies against cancer. \nDuring this webinar\, the following topics will be discussed: \nThe use of syngeneic tumor models to evaluate the ability of co-engineered murine CAR T cells to reprogram the TME and boost T cell function\nThe use of low doses of irradiation to inflame cold tumors and render them responsive to rational combinatorial immunotherapy\nThe novel STOP-CAR integrates efficacy and safety directly into CAR design
URL:https://www.masslifesciences.com/event/engineering-strategies-for-improving-adoptive-t-cell-therapy-against-cancer/
LOCATION:Virtual
ORGANIZER;CN="Creative Biolabs":MAILTO:marketing@creative-biolabs.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220413T150000
DTEND;TZID=America/New_York:20220413T180000
DTSTAMP:20260426T050036
CREATED:20220127T221925Z
LAST-MODIFIED:20220127T221925Z
UID:15651-1649862000-1649872800@www.masslifesciences.com
SUMMARY:MassBio Career Fair 2022: Exhibitor Registration
DESCRIPTION:Join MassBio for its second annual Virtual Career Fair on April 13th from 3-6pm. Connect with the brightest talent in the life science industry by registering as an exhibitor and display your open positions. \nRegistration for companies closes March 11th and then job seeker application will open.
URL:https://www.masslifesciences.com/event/massbio-career-fair-2022-exhibitor-registration/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211214T183000
DTEND;TZID=America/New_York:20211214T193000
DTSTAMP:20260426T050036
CREATED:20211123T220212Z
LAST-MODIFIED:20211123T220212Z
UID:14950-1639506600-1639510200@www.masslifesciences.com
SUMMARY:Koch Institute Directors Panel
DESCRIPTION:Celebrate the enduring legacy of cancer research at MIT. Current and former directors reflect on the past five decades of progress—from seminal discoveries in molecular biology and immunology to new innovations in nanotechnology and precision medicine—and look ahead to future advancements in the fight against cancer. Join in the conversation as we commemorate the people\, projects\, and promise of integrative cancer research. \nFeaturing \nPhillip Sharp\, PhD\nDirector: 1985–1991\nInstitute Professor and Professor of Biology \nRichard Hynes\, PhD\nDirector: 1991–2001\nDaniel K. Ludwig Professor for Cancer Research \nTyler Jacks\, PhD\nDirector: 2001–2021\nDavid H. Koch (1962) Professor of Biology and Daniel K. Ludwig Scholar \nMatthew Vander Heiden\, MD\, PhD\nDirector: 2021–present\nLester Wolfe (1919) Professor of Molecular Biology and Professor of Biology \nModerated by Susan Hockfield\, PhD\nMIT President Emerita and Professor of Neuroscience
URL:https://www.masslifesciences.com/event/koch-institute-directors-panel/
LOCATION:Virtual
ORGANIZER;CN="Koch Institute for Integrative Cancer Research at MIT":MAILTO:kievents@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210727T170000
DTEND;TZID=America/New_York:20210807T170000
DTSTAMP:20260426T050036
CREATED:20210713T123813Z
LAST-MODIFIED:20210713T123837Z
UID:14213-1627405200-1628355600@www.masslifesciences.com
SUMMARY:Open Enrollment Program Leading Digital Transformation in Health Care
DESCRIPTION:This Harvard Medical School online program provides you with the knowledge\, tools and strategies to design and implement technology-enabled change initiatives in health care. It will feature a combination of live virtual class sessions and self-paced learning and discussions. A certificate of completion will be provided.
URL:https://www.masslifesciences.com/event/open-enrollment-program-leading-digital-transformation-in-health-care/
LOCATION:Virtual
END:VEVENT
END:VCALENDAR